Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-blind Placebo-controlled Clinical Study to Evaluate the Effects and Safety of Iron Prophylaxis With Ferro IBSA on Iron Homeostasis in Healthy Pregnant Women.

NCT07884617 is registered in ClinicalTrials.gov with IBSA Farmaceutici Italia Srl as lead sponsor.

NCT NCT07884617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07884617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-blind Placebo-controlled Clinical Study to Evaluate the Effects and Safety of Iron Prophylaxis With Ferro IBSA on Iron Homeostasis in Healthy Pregnant Women.
Lead sponsor
IBSA Farmaceutici Italia Srl
Phase
Not applicable
Overall status
Recruiting
Start date
May 18, 2026
Completion date
June 30, 2028
Enrollment
162 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia in pregnancy, iron deficiency in pregnancy